Exact Sciences (EXAS) Research & Development (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Research & Development data on file, last reported at $191.5 million in Q4 2025.

• Research & Development for Q4 2025 came in at $191.5 million, up 95.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $523.0 million (up 21.29% YoY), and the FY2025 annual result was $523.0 million, up 21.29% from the prior year.
• Research & Development rose to $191.5 million in Q4 2025 per EXAS's latest filing, from $117.3 million in the prior quarter.
• Over five years, Research & Development peaked at $191.5 million in Q4 2025 and troughed at $75.4 million in Q3 2021.
• A 5-year average of $108.0 million and a median of $105.7 million in 2022 frame the typical range for Research & Development.
• On a YoY basis, Research & Development climbed as much as 225.15% in 2021 and fell as far as 80.18% in 2021.
• A 5-year view of Research & Development shows it stood at $88.5 million in 2021, then rose by 7.41% to $95.0 million in 2022, then increased by 21.19% to $115.2 million in 2023, then declined by 15.17% to $97.7 million in 2024, then surged by 95.99% to $191.5 million in 2025.
• Business Quant data shows EXAS's Research & Development at $191.5 million in Q4 2025, $117.3 million in Q3 2025, and $108.9 million in Q2 2025.